The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05531565
Brief Title: A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

First Submitted : August 19, 2022
First Submitted that Met QC Criteria : September 2, 2022
First Posted : September 8, 2022

Last Update Submitted that Met QC Criteria : June 14, 2024
Last Update Posted : June 17, 2024